Additionally, this study breaks new ground by demonstrating that liquiritin, a component of licorice, shows promise in combating HER2-positive breast cancer, expanding the understanding of licorice’s anticancer properties beyond isoliquiritigenin. This evidence concerns the gene ERBB2 and breast carcinoma.